SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Furiex Pharmaceuticals, Inc. Confirms Takeda Pharmaceutical Co. Ltd. Launches LIOVEL(R) LD and LIOVEL(R) HD, a Fixed Dose Combination of NESINA(R) and ACTOS(R), for Type 2 Diabetes in Japan